Advancing innovation in kidney care
Panoramic Science is the partner of choice for pharma sponsors and CROs looking to advance scientific innovation across the cardio-renal-metabolic spectrum.
Panoramic Science is the partner of choice for pharma sponsors and CROs looking to advance scientific innovation across the cardio-renal-metabolic spectrum.
Breakthroughs in kidney care begins with scientific innovation.
Panoramic Science, the clinical research division of Panoramic Health, partners with sponsors and drug developers to bring the latest therapeutic innovations to patients living with kidney disease.
Our network of clinical research sites, located within 30+ community-based nephrology partner practices, is uniquely positioned to provide speedy solutions to the real-world challenges pharma sponsors face: rapid enrollment via EMR-integrated patient screening tools, study activation, centralized support services, and timely trial data.
In addition, we maintain the largest real-time CKD patient database with 1M+ de-identified patient records which supports the implementation of post-market data studies and health outcomes research.
Kidney research faces several challenges that impact the development of effective treatments and innovations in cardio-renal-metabolic care, such as:
Complex eligibility criteria and retention issues create bottlenecks in cardio-renal-metabolic disease trial recruitment.
Sponsors struggle to find highly engaged principal investigators with reliable access to qualified patients.
Because we activate research sites at practices we’re already partnered with, sponsors can more quickly identify and qualify eligible patients and overcome a key obstacle of locating a diverse and representative population.
Access our growing network of 20+ clinical research sites integrated within nephrology practices and leverage our expert principal investigators, and dedicated study coordinators for seamless clinical trial operations. In addition, sponsors have a single point of contact for activating trials at multiple sites.
Our database of 1M+ longitudinal patient records at the intersection of cardio-renal-metabolic diseases provides an entryway for comparative effectiveness and health outcomes research. Layered on top of the database is a data science team to drive clinical intelligence, custom query building, and ongoing data capture.
Our sites follow the best standard operating procedures for quality and good clinical practice (GCP) compliance. With ongoing support from our Quality team, we ensure audit-readiness and the ability to deliver data in a timely manner.
The Panoramic Science team doesn’t just activate trials — we work as a true partner in clinical research, supporting pharma and CROs from study design through successful execution.
Our comprehensive suite of capabilities and services is designed to advance research across the cardio-renal-metabolic spectrum of care, including:
At Panoramic Science, we work across the spectrum of pharmaceutical, biotechnology, and medical device companies offering therapies for patients with kidney disease. Some of our partners include:
We specialize in nephrology, but also conduct research in cardio-renal, metabolic, and comorbid conditions like diabetes, hypertension, and obesity.
Patient adherence to protocol and retention on study is convenient and easy, since their research visits take place within the existing care process and practice of their treating nephrologist.
We support Phase I-IV clinical trials, real-world evidence (RWE) studies, and post-market surveillance research across nephrology and related therapeutic areas, including cardiovascular, metabolic, and rare kidney diseases.
We are embedded within the leading nephrology-focused provider group, which enables us to reach hundreds of thousands of CKD/ESKD patients. Powered by our partner practices, we also maintain the largest CKD database, offering real-world clinical data from 1M+ patient records to support retrospective data studies, quality improvement projects and health outcomes research.
Our streamlined startup process, pre-qualified research sites, and experienced investigators allow us to activate sites faster than traditional models, significantly reducing trial initiation timelines. In addition, we offer sponsors and CROs a single point of contact for activating trials at multiple sites.
